LGALS3 and periodontal disorder: Future studies are needed to dissect the precise role of Gal-3 in maintaining the balance between oral microbiota and the host inflammatory/immune response and periodontal diseases pathogenesis and, considering previously shown therapeutic effects of its inhibition in chronic inflammatory diseases and even possibility of targeted delivery, to point out the Gal-3 as a possible therapeutic target in periodontal disease.